Your browser doesn't support javascript.
loading
Design, synthesis, biological evaluation and molecular docking study of 2,4-diarylimidazoles and 2,4-bis(benzyloxy)-5-arylpyrimidines as novel HSP90 N-terminal inhibitors.
Yang, Man; Li, Chenyao; Li, Yajing; Cheng, Chen; Shi, Meiyun; Yin, Lei; Xue, Hongyu; Liu, Yajun.
Affiliation
  • Yang M; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Li C; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Li Y; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Cheng C; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Shi M; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Yin L; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Xue H; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
  • Liu Y; School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panjin, China.
J Enzyme Inhib Med Chem ; 37(1): 2551-2565, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36120957
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Imidazolidines / Antineoplastic Agents Limits: Humans Language: En Journal: J Enzyme Inhib Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2022 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Imidazolidines / Antineoplastic Agents Limits: Humans Language: En Journal: J Enzyme Inhib Med Chem Journal subject: BIOQUIMICA / QUIMICA Year: 2022 Document type: Article Affiliation country: China Country of publication: Reino Unido